Our laboratory has contributed to two newly published studies investigating the role of Siglec-7, an inhibitory receptor expressed on natural killer (NK) cells, in immune regulation through its interactions with glycan ligands in both cancer and bacterial infection contexts. In the first study, researchers examined how Siglec-7 recognises the tumour-associated ganglioside GD3, a disialylated glycosphingolipid […]
